作者: Per Engervall , Magnus Björkholm
DOI: 10.1007/BF02988841
关键词:
摘要: Improvement in supportive care including the introduction of new antibiotics, antiviral and antifungal agents haematopoietic growth factors have all contributed to a decreased chemotherapy-related mortality morbidity cancer patients. However, infection during neutropenia is still major complication great concern for clinician responsible patient. Management infectious complications neutropenic patient reviewed.